Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 26 February 2018

Indication(s)

Clopidogrel/Acetylsalicylic acid Zentiva is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (ASA).
Clopidogrel/Acetylsalicylic acid Zentiva is a fixed-dose combination medicinal product for continuation of therapy in:

• Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention
• ST segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Oral Anticoagulation Reversal

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Sleep Apnea

Sleep Apnea

Sleep apnea is a chronic condition characterised by recurrent interruptions in breathing throughout the sleep cycle. Learn about the two main types of sleep apnea and hear from experts as they present the latest research at the Sleep and Breathing conference (Marseille, 2019).

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/001144
Orphan designation No
Date First Approved 15-03-2010
Type Medicinal product subject to medical prescription
Marketing authorisation holder Sanofi-aventis groupe